The COVID-19 pandemic created ripple effects across all of health care, especially for at-risk populations like cancer patients. Early in the pandemic, the National Cancer Institute initiated a study to examine the intersection of cancer and COVID-19 diagnoses. More than two years later, we discuss with NCI Head of Breast Cancer and Melanoma Therapeutics Dr. Larissa Korde from the Clinical Investigations Branch on the status of the study, some of the preliminary findings and how it’s evolved.
Cancer HealthCast
26m listen
A Look Into COVID-19’s Impact on Cancer Patients
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
-
Dr. Larissa Korde Head, Breast Cancer and Melanoma Therapeutics NCI
Related Content
-
The Year Ahead: FBI’s 2025 Cybersecurity Priorities
The FBI is increasing awareness of vulnerabilities and employing AI-enabled tools to secure networks from sophisticated cyber threats.
19m listen -
OPM Navigates AI Governance Through People
OPM's Taka Ariga explores AI's role in an efficient federal workforce and operations, focusing on trust, data integrity and storytelling.
19m listen -
HHS CIO Eyes Special Cyber Measures to Secure Data
Data security and customer experience are top priorities for Jennifer Wendel, the newly confirmed permanent CIO at the Department of Health and Human Services (HHS).
25m listen -
Coming Soon: AI GovCast Season 2 Explores Federal Artificial Intelligence
The first season of AI GovCast brought listeners the voices at the forefront of government's AI revolution. Coming Jan. 14, season two will dive deeper into AI governance, use cases and implementation.
1m listen
